192 related articles for article (PubMed ID: 34360817)
1. Development of [
Teodoro R; Gündel D; Deuther-Conrad W; Ueberham L; Toussaint M; Bormans G; Brust P; Moldovan RP
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360817
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Design, Optimization, and Development of [
Gündel D; Deuther-Conrad W; Ueberham L; Kaur S; Otikova E; Teodoro R; Toussaint M; Lai TH; Clauß O; Scheunemann M; Bormans G; Bachmann M; Kopka K; Brust P; Moldovan RP
J Med Chem; 2022 Jul; 65(13):9034-9049. PubMed ID: 35771668
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor.
Saccomanni G; Pascali G; Carlo SD; Panetta D; De Simone M; Bertini S; Burchielli S; Digiacomo M; Macchia M; Manera C; Salvadori PA
Bioorg Med Chem Lett; 2015 Jun; 25(12):2532-5. PubMed ID: 25956416
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [
Teodoro R; Gündel D; Deuther-Conrad W; Kazimir A; Toussaint M; Wenzel B; Bormans G; Hey-Hawkins E; Kopka K; Brust P; Moldovan RP
J Med Chem; 2023 Oct; 66(20):13991-14010. PubMed ID: 37816245
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated CRA13 analogues: Synthesis, in vitro evaluation, radiosynthesis, in silico and in vivo PET study.
Hassan AHE; Park KT; Kim HJ; Lee HJ; Kwon YH; Hwang JY; Jang CG; Chung JH; Park KD; Lee SJ; Oh SJ; Lee YS
Bioorg Chem; 2020 Jun; 99():103834. PubMed ID: 32334193
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of cannabinoid type 2 receptors with [
Pottier G; Gómez-Vallejo V; Padro D; Boisgard R; Dollé F; Llop J; Winkeler A; Martín A
J Cereb Blood Flow Metab; 2017 Mar; 37(3):1163-1178. PubMed ID: 28079433
[TBL] [Abstract][Full Text] [Related]
9. From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging.
Caillé F; Cacheux F; Peyronneau MA; Jego B; Jaumain E; Pottier G; Ullmer C; Grether U; Winkeler A; Dollé F; Damont A; Kuhnast B
Mol Pharm; 2017 Nov; 14(11):4064-4078. PubMed ID: 28968497
[TBL] [Abstract][Full Text] [Related]
10. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor.
Moldovan RP; Teodoro R; Gao Y; Deuther-Conrad W; Kranz M; Wang Y; Kuwabara H; Nakano M; Valentine H; Fischer S; Pomper MG; Wong DF; Dannals RF; Brust P; Horti AG
J Med Chem; 2016 Sep; 59(17):7840-55. PubMed ID: 27500461
[TBL] [Abstract][Full Text] [Related]
11. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.
Evens N; Vandeputte C; Muccioli GG; Lambert DM; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Bioorg Med Chem; 2011 Aug; 19(15):4499-505. PubMed ID: 21737287
[TBL] [Abstract][Full Text] [Related]
14.
Kirjavainen AK; Forsback S; López-Picón FR; Marjamäki P; Takkinen J; Haaparanta-Solin M; Peters D; Solin O
Nucl Med Biol; 2018 Jan; 56():39-46. PubMed ID: 29172120
[TBL] [Abstract][Full Text] [Related]
15. Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging.
Modemann DJ; Mahardhika AB; Yamoune S; Kreyenschmidt AK; Maaß F; Kremers S; Breunig C; Sahlmann CO; Bucerius J; Stalke D; Wiltfang J; Bouter Y; Müller CE; Bouter C; Meller B
Eur J Med Chem; 2022 Mar; 232():114138. PubMed ID: 35193075
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of [
Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue.
Haider A; Spinelli F; Herde AM; Mu B; Keller C; Margelisch M; Weber M; Schibli R; Mu L; Ametamey SM
Eur J Med Chem; 2018 Feb; 145():746-759. PubMed ID: 29353725
[TBL] [Abstract][Full Text] [Related]
20. Development of
Lai TH; Schröder S; Toussaint M; Dukić-Stefanović S; Kranz M; Ludwig FA; Fischer S; Steinbach J; Deuther-Conrad W; Brust P; Moldovan RP
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
